Page last updated: 2024-08-21

quinazolines and Infectious Diseases

quinazolines has been researched along with Infectious Diseases in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	1 (33.33)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Biffi, A; Blijlevens, N; de la Camara, R; Fagioli, F; Galaverna, F; Gil, L; Groll, AH; Holler, E; Junghanss, C; Knelange, N; Lioure, B; Ljungman, P; Medinger, M; Mielke, S; Mikulska, M; Nikolousis, E; Rodriguez, MAB; Solano, C; Šrámek, J; Styczyński, J; Taskinen, M; Tridello, G; Tsirigotis, P; Wendel, L; Xhaard, A	1
Chauhan, PM; Sharma, M	1
Kano, Y	1

Reviews

2 review(s) available for quinazolines and Infectious Diseases

Article	Year
Dihydrofolate reductase as a therapeutic target for infectious diseases: opportunities and challenges. Future medicinal chemistry, 2012, Volume: 4, Issue:10 Topics: Animals; Anti-Infective Agents; Antimalarials; Bacteria; Communicable Diseases; Drug Resistance, Microbial; Folic Acid Antagonists; Humans; Parasites; Pyrimidines; Quinazolines; Tetrahydrofolate Dehydrogenase	2012
[Adverse drug reactions induced by molecular target therapy]. Arerugi = [Allergy], 2007, Volume: 56, Issue:12 Topics: Anaphylaxis; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Benzamides; Cetuximab; Communicable Diseases; ErbB Receptors; Etanercept; Fusion Proteins, bcr-abl; Gefitinib; Humans; Imatinib Mesylate; Immunoglobulin G; Infliximab; Lung Diseases; Piperazines; Protein-Tyrosine Kinases; Pyrimidines; Quinazolines; Receptors, Tumor Necrosis Factor; Skin Diseases; Tumor Necrosis Factor-alpha	2007

Article

Year

Dihydrofolate reductase as a therapeutic target for infectious diseases: opportunities and challenges.

Future medicinal chemistry, 2012, Volume: 4, Issue:10

Topics: Animals; Anti-Infective Agents; Antimalarials; Bacteria; Communicable Diseases; Drug Resistance, Microbial; Folic Acid Antagonists; Humans; Parasites; Pyrimidines; Quinazolines; Tetrahydrofolate Dehydrogenase

2012

[Adverse drug reactions induced by molecular target therapy].

Arerugi = [Allergy], 2007, Volume: 56, Issue:12

Topics: Anaphylaxis; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Benzamides; Cetuximab; Communicable Diseases; ErbB Receptors; Etanercept; Fusion Proteins, bcr-abl; Gefitinib; Humans; Imatinib Mesylate; Immunoglobulin G; Infliximab; Lung Diseases; Piperazines; Protein-Tyrosine Kinases; Pyrimidines; Quinazolines; Receptors, Tumor Necrosis Factor; Skin Diseases; Tumor Necrosis Factor-alpha

2007

Other Studies

1 other study(ies) available for quinazolines and Infectious Diseases

Article	Year
Use of letermovir in off-label indications: Infectious Diseases Working Party of European Society of Blood and Marrow Transplantation retrospective study. Bone marrow transplantation, 2021, Volume: 56, Issue:5 Topics: Acetates; Adult; Antiviral Agents; Bone Marrow; Child; Communicable Diseases; Cytomegalovirus; Hematopoietic Stem Cell Transplantation; Humans; Off-Label Use; Quinazolines; Retrospective Studies	2021

Article

Year

Use of letermovir in off-label indications: Infectious Diseases Working Party of European Society of Blood and Marrow Transplantation retrospective study.

Bone marrow transplantation, 2021, Volume: 56, Issue:5

Topics: Acetates; Adult; Antiviral Agents; Bone Marrow; Child; Communicable Diseases; Cytomegalovirus; Hematopoietic Stem Cell Transplantation; Humans; Off-Label Use; Quinazolines; Retrospective Studies

2021